-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Neurocrine Biosciences Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Neurocrine Biosciences Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $184M, a 30.2% increase year-over-year.
- Neurocrine Biosciences Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $579M, a 184% increase year-over-year.
- Neurocrine Biosciences Inc annual Operating Income (Loss) for 2023 was $251M, a 0.76% increase from 2022.
- Neurocrine Biosciences Inc annual Operating Income (Loss) for 2022 was $249M, a 143% increase from 2021.
- Neurocrine Biosciences Inc annual Operating Income (Loss) for 2021 was $103M, a 37.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)